07682612 is referenced by 40 patents and cites 81 patents.

Chronic Lymphocytic Leukemia (CLL) may be treated with antibodies directed against the CD20 antigen.

Title
Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
Application Number
9/436347
Publication Number
7682612 (B1)
Application Date
November 9, 1999
Publication Date
March 23, 2010
Inventor
Susan Desmond Hellmann
Alamo
CA, US
John G Curd
Hillsborough
CA, US
Antonio J Grillo López
Rancho Santa Fe
CA, US
Christine A White
Rancho Santa Fe
CA, US
Agent
Sidley Austin
Assignee
Genentech
CA, US
Biogen Idec
MA, US
IPC
A61K 51/00
A61K 39/395
View Original Source